Effects Analysis of Clinical Curative Effect and Immune Function on Inflammatory on Infliximab Combined with Traditional Chinese Medicine Bowel Disease Treatment during Active Stage
LIU Wei
Panjin Central Hospital, Liaoning Panjin 124010, China
Abstract：Objective: To study effects of infliximab (IFX) combined with traditional Chinese medicine (TCM) on clinical curative effect and immune function in inflammatory bowel disease (IBD) treatment during active stage. Methods: 94 IBD patients during active stage were enrolled. According to simple random and voluntary principle, they were divided into control group (8 cases) and study group (56 cases). The control group was treated with IFX, while study group was treated with TCM on basis of control group. The inflammatory cytokines, lymphocyte subsets, scores of TCM syndromes and clinical curative effect before and after treatment was compared between the two groups. Results: The total response rate of treatment in study group was significantly higher than that in control group (χ2=4.351, P<0.05). Before treatment, there were no significant differences in levels of inflammatory factors (CRP, IL-6, TNF-α) between the two groups (P>0.05). After treatment, decrease amplitude of the above indexes in study group was significantly greater than that in control group (P<0.05). Before treatment, there were no significant differences in levels of lymphocyte subsets (NK cells, CD3+, CD4+, CD4+/CD8+) between the two groups (P>0.05). After treatment, increase amplitude of the above indexes in study group was significantly greater than that in control group (P<0.05). Before treatment, scores of TCM syndromes in control group and study group were (14.96±4.50) points and (15.24±4.16) points, respectively (P>0.05). After treatment, scores of TCM syndromes in control group and study group were (7.34±0.68) points and (5.65±0.49) points. Compared with that before treatment, score decrease amplitude in study group was significantly greater than that in the control group (P<0.05). Conclusion: The curative effect of IFX combined with Anchang Yuyang decoction is significant, which can reduce levels of inflammatory factors, enhance levels of lymphocyte subsets, improve total response rate of treatment, improve immune function, reduce scores of TCM syndromes and effectively treat IBD patients during active stage.
刘巍. 中英夫利昔单抗联合中药治疗炎症性肠病活动期的临床疗效及对免疫功能的影响分析[J]. 河北医学, 2020, 26(1): 150-153.
LIU Wei. Effects Analysis of Clinical Curative Effect and Immune Function on Inflammatory on Infliximab Combined with Traditional Chinese Medicine Bowel Disease Treatment during Active Stage. HeBei Med, 2020, 26(1): 150-153.
2020, Vol. 26 
冀公网安备13080202000677号